RNA-Based Drugs Fuel Growth in USD 6.94 Billion Transthyretin Amyloidosis Market

The transthyretin amyloidosis treatment market is experiencing robust growth, valued at USD 6.94 billion in 2024 and expected to soar to USD 20.35 billion by 2033, according to IMARC Group. This remarkable expansion, driven by an impressive CAGR of 11.60% from 2025 to 2033, is fueled by groundbreaking advances in therapeutic options and rising awareness. Visit us- https://www.imarcgroup.com/tra....nsthyretin-amyloidos